16
Views
18
CrossRef citations to date
0
Altmetric
Original Article

Progression of Essential Thrombocythemia to Blastic Crisis Via Idiopathic Myelofibrosis

, , , &
Pages 423-426 | Received 19 Jul 1992, Published online: 01 Jul 2009

References

  • Adam J. A., Barrett A. J., Beard J., McCarthy D. M. Primary polycythaemia, essential thrombocythaemia and myelofibrosis. Three facets of a single disease process?. Acta Haemal 1988; 79: 33–37
  • Bellucci S., Janvier M., Tobelem G., Flandrin G., Charpak Y., Berger R., Boiron M. Essential thrombocythe-mias. Clinical evolutionary and biological data. Cancer 1986; 58: 2440–2447
  • Borgstrom G. H., Kuuntila S., Ruutu T., Pakkala A., Lahtinen R., de la Chapelle A. Abnormalities of chromosome 13 in myelofibrosis. Scand. J. Haematol 1984; 33: 15–21
  • Emilia G., Torelli G., Sacchi S., Donelli A. Chromosomal abnormalities in essential thrombocythemia. Cancer Genet Cytogenet 1985; 18: 91–93
  • Fenaux P., Simon M., Caulier M. T., Lai J. L., Goudemand J., Bauters F. Clinical course of essential thrombocythemia in 147 cases. Cancer 1990; 66: 549–556
  • Fialkow P. J., Faguet G. B., Jacobson R. J., Waidya K., Murphy S. Evidence that essential thrombocythemia is a clonal disorder with origin in a multipotent stem cell. Blood 1981; 58: 916–919
  • Frei-Lahr D., Barton J. C., Hoffman R., Burkett L. L., Prchal J. T. Blastic transformation of essential thrombocythemia: dual expression of myelomonoblastic-megacaryoblastic phenotypes. Blood 1984; 63: 866–872
  • Geller S. A., Shapiro E. Acute leukemia as a natural sequel to primary thrombocythemia. Am. J. Clin. Pathol 1982; 77: 353–356
  • Hehlmann R., Jahn M., Baumann B., Kopcke W. Essential thrombocythemia. Clinical characteristics and course of 61 cases. Cancer 1988; 61: 2487–2496
  • Janssen J. W. G., Anger B. R., Drexler H. G., Bartram C. R., Heimpel H. Essential thrombocythemia in two sisters originating from different stem cell levels. Blood 1990; 75: 1633–1636
  • Kimura A., Fujimoto T., Inada T., Imamura N., Oguma N., Kajihara H., Mtasiwa D. M., Katoh O., Fujimura K., Kuramoto A. Blastic transformation in essential thrombocythemia. In vitro differentiation of blast cells into granulocytic, erythroid and megakaryocytic lineages. Cancer 1990; 65: 1538–1544
  • Lawrence J. H., Winchell H. S., Donald W. G. Leukemia in polycythaemia vera: relationship to splenic myeloid metaplasia and therapeutic radiation dose. Ann. Intern. Med 1969; 70: 763–771
  • Liberato N. L., Barosi G., Costa A., D'Elia P., Boccaccio P. Myelofibrosis with myeloid metaplasia following essential thrombocythemia. Acta Haemal 1989; 82: 150–153
  • Modan B., Lilienfeld A. M. Polycythemia vera and leukemia–The role of radiation treatment. A study of 1222 patients. Medicine 1965; 44: 305–344
  • Murphy S., Hand H., Rosenthal D., Laszlo J. Essential thrombocythernia: An interim report from the policythemia vera study group. Semin. Hematol 1986; 23: 177–182
  • Rege-Cambrin G., Mecucci C., Tricot G., Michaux J. L., Louwagie A., Van Hove W., Francart H., Van Den Berghe H. A chromosomal profile of polycythemia vera. Cancer Genet. Cytogenet 1987; 25: 233–245
  • Reiffers J., Dachary D., David B. Megakaryoblas-tic transformation of primary thrombocythemia. Acta Haemal 1985; 73: 228–245
  • Sedlacek S. M., Curtis J. L., Weintraub J., Levin J. Essential thrombocythemia and leukemic transformation. Medicine 1986; 65: 353–364
  • Sessarego M., Defferrari R., Dejana A. M., Rebuttato A. M., Fugazza G., Salvidio E., Ajmar F. Cytogenetic analysis in essential thrombocythemia at diagnosis and transformation. A 12 years study. Cancer Genet Cytogenet 1989; 43: 57–65
  • Third International Workshop on Chromosome in leukemia. Cancer Genet Cytogenet 1981; 4: 138–142, 1980: report on essential thrombocythemia
  • Toh B. T., Gregory S. A., Knospe W. H. Acute leukemia following treatment of polycythemia vera and essential thrombocythemia with uracil mustard. Am. J. Hematol 1988; 28: 58–60
  • Weinfeld A., Westin J., Ridell B., Swolin B. Polycythemia vera terminating in acute leukemia: a clinical, cytogenetic and morphologic study in 8 patients treated with alkylating agents. Scand. J. Haematol 1977; 19: 255–272

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.